Viridian Therapeutics
VRDN
VRDN
51 hedge funds and large institutions have $37.4M invested in Viridian Therapeutics in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Holders
51
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$430K | |
| 2 | +$196K | |
| 3 | +$193K | |
| 4 |
MFAM
Motley Fool Asset Management
Alexandria,
Virginia
|
+$80.2K |
| 5 |
D.E. Shaw & Co
New York
|
+$74.1K |
Top Sellers
| 1 | -$2.75M | |
| 2 | -$1.17M | |
| 3 | -$301K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$252K |
| 5 |
Morgan Stanley
New York
|
-$189K |